fbpx
CoronavirusDrug Safety

FDA Approves Trials to Test the Effectiveness of Anti-Malarial Drugs Against COVID-19

As touted by President Donald Trump, on Sunday, an emergency authorization was issued by the Food and Drug Administration (FDA) in Washington. It was regarding the use of chloroquine and hydroxychloroquine – both anti-malaria drugs, for experimental coronavirus treatments, despite the inconclusive clinical proof of their efficacy.

However, on Sunday, the Department of Health and Human Services had announced that distribution of hydroxychloroquine and chloroquine products can be done by doctors, and they may prescribe these drugs to hospitalized teen and adult patients that are infected with COVID-19, as appropriate, in the situation where the availability or feasibility of a clinical trial are not seen.

According to HHS, 30 million doses of hydroxychloroquine has already been given by Germany’s Sandoz, to the Strategic National Stockpile – the inventory of medical supplies for public health emergencies, of the Federal Government. Meanwhile, Bayer has reported having donated a million doses of chloroquine, according to the international media.

Read the source article at Home – Cannabis Health Insider

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button
    Close
    Close